« More new CPT codes a... | Main | How the E/M code RVU... »

Wednesday Jan 06, 2021

COVID-19 vaccines coding guide

The CPT Editorial Panel has approved unique codes for multiple COVID-19 vaccines, as well as administration codes for each dose of those vaccines. This list will be updated as more codes are approved.

ManufacturerVaccine codeDescriptionAdministration codes
Manufacturer:

Pfizer

Vaccine code:

91300

Description:

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted, for intramuscular use

Administration codes:

• 0001A (1st dose)

• 0002A (2nd dose)

• 0003A (3rd dose)

Manufacturer:

Moderna

Vaccine code:

91301

Description:

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage, for intramuscular use

Administration codes:

• 0011A (1st dose)

• 0012A (2nd dose)

Manufacturer:

AstraZeneca/Oxford

Vaccine code:

91302

Description:

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x1010 viral particles/0.5mL dosage, for intramuscular use

Administration codes:

• 0021A (1st dose)

• 0022A (2nd dose)

Manufacturer: Janssen (Johnson & Johnson)Vaccine code: 91303Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x1010 viral particles/0.5mL dosage, for intramuscular useAdministration codes: • 0031A (single-dose vaccine)
Manufacturer: NovavaxVaccine code: 91304Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage, for intramuscular useAdministration codes:

• 0041A (1st dose)

• 0042A (2nd dose)

 

All codes are provisional, pending Emergency Use Authorization or approval by the U.S. Food and Drug Administration. The AMA has published a special edition CPT Assistant guide(www.ama-assn.org), which includes an appendix(www.ama-assn.org) to help identify each vaccine’s product code and administration code.

The AAFP is monitoring every aspect of the COVID-19 vaccine development process, including the Food and Drug Administration's Emergency Use Authorization reviews. Visit aafp.org/covidvaccine for updates to help prepare your practice and patients for the vaccines.

Posted at 11:45PM Jan 06, 2021 by FPM Editors

« More new CPT codes a... | Main | How the E/M code RVU... »


CURRENT ISSUE

RECENT POSTS

SEARCH THIS BLOG


TOPICS

DISCLAIMER

The views expressed here do not necessarily reflect the opinions of FPM or the AAFP. Some payers may not agree with the advice given. This is not a substitute for current CPT and ICD-9 manuals and payer policies. All comments are moderated and will be removed if they violate our Terms of Use.

FEEDS